Journal of Immunotherapy · 2010 · 26 citations · 32 references
MedicineImmunologyOncologyCancer ImmunologyImmunotherapyTumor ImmunologyAntitumor T Cell ResponsesCancer ImmunotherapyCombination ImmunotherapyCytotoxic T Lymphocyte ResponsesImmunotherapy For Skin CancerTumor-infiltrating LymphocytesCancer AntigensCd4 Positive T CellsCd4 T-cell DepletionLymphocyte PhysiologyMelanoma ImmunotherapyPhase I Clinical TrialsShort-course ChemotherapyT-cell Homeostatic Proliferation
Recent immunotherapy trials have shown that lymphodepletion induced by short-term chemotherapy favors subsequent expansion of adoptively transferred T cells, by homeostatic mechanisms. To take advantage of this effect, novel regimens are being developed with the aim to enhance tumor immunity and reduce treatment toxicity. We have designed a clinical phase I trial combining chemotherapy, reinfusion of PBMC containing Melan-A(MART-1)-specific T cells, and vaccination with Melan-A peptide in Incomplete Freund's Adjuvant. Treatment with Busulfan plus Fludarabine depleted lymphocytes only weakly. Cyclophosphamide (CTX) plus Fludarabine depleted lymphocytes more profoundly, with a maximal effect using high doses of CTX. It is interesting to note that, the degree of homeostatic T-cell proliferation correlated tightly with the extent of lymphodepletion. As compared with CD4 T cells, CD8 T cells showed higher susceptibility to chemotherapy, followed by more rapid homeostatic proliferation and recovery, resulting in strong inversions of CD4/CD8 ratios. Despite efficient homeostatic proliferation of total CD4 and CD8 T cells, the frequency of CD8 T cells specific for Melan-A and cancer-testis antigens remained relatively low. In contrast, EBV-specific T cells expanded and reached high numbers. We conclude that short-term chemotherapy promoted homeostatic lymphocyte proliferation depending on the intensity of lymphocyte depletion, however without preferential expansion of tumor antigen-specific T cells.
32
Elizabeth Walter, Philip D. Greenberg, M. Jean Gilbert et al. · New England Journal of Medicine · 1995 · 1.8K citations
Mark E. Dudley, John R. Wunderlich, James Chih‐Hsin Yang et al. · Journal of Clinical Oncology · 2005 · 1.6K citations · Full text
Medicine, Immunology, Oncology +17
Interleukin-7 mediates the homeostasis of naïve and memory CD8 T cells in vivo
Kimberly S. Schluns, William C. Kieper, Stephen C. Jameson et al. · Nature Immunology · 2000 · 1.6K citations
Luca Gattinoni, Steven E. Finkelstein, Christopher A. Klebanoff et al. · The Journal of Experimental Medicine · 2005 · 1K citations · Full text
Life Sciences, Immunology, Oncology +17